Cost-Effectiveness Analysis of Camrelizumab Immunotherapy versus Docetaxel or Irinotecan Chemotherapy as Second-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
-
Published:2021-11
Issue:
Volume:Volume 13
Page:8219-8230
-
ISSN:1179-1322
-
Container-title:Cancer Management and Research
-
language:en
-
Short-container-title:CMAR
Author:
Lin Ying-TaoORCID,
Chen Ying,
Liu Tian-XiuORCID,
Kuang Fang,
Huang Ping
Publisher
Informa UK Limited
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献